Spanish biotech startup Adaptam Therapeutics has raised €3 million in a pre-seed financing spherical led by Criteria Bio Ventures. The funding will speed up the event of Adaptam’s first-in-class antibody-based therapies, together with antibody-drug conjugates (ADCs) and bispecific antibodies, aimed toward treating a number of types of most cancers. Breaking the obstacles of the tumour... Read More








:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)



Recent Comments